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Abstract
Background: We recently reported poor inter-observer agreement in identifying and quantifying
individual ultrasonographic features of polycystic ovaries. Our objective was to determine the
effect of a training workshop on reducing inter-observer variation in the ultrasonographic
evaluation of polycystic ovaries.
Methods: Transvaginal ultrasound recordings from thirty women with polycystic ovary syndrome
(PCOS) were evaluated by three radiologists and three reproductive endocrinologists both before
and after an ultrasound workshop. The following endpoints were assessed: 1) follicle number per
ovary (FNPO), 2) follicle number per single cross-section (FNPS), 3) largest follicle diameter, 4)
ovarian volume, 5) follicle distribution pattern and 6) presence of a corpus luteum (CL). Lin's
concordance correlation coefficients (rho) and kappa statistics for multiple raters (kappa) were
used to assess level of inter-observer agreement (>0.80 good, 0.60 – 0.80 moderate/fair, <0.60
poor).
Results: Following the workshop, inter-observer agreement improved for the evaluation of FNPS
(rho = 0.70, delta rho = +0.11), largest follicle diameter (rho = 0.77, delta rho = +0.10), ovarian
volume (rho = 0.84, delta rho = +0.12), follicle distribution pattern (kappa = 0.80, delta kappa =
+0.21) and presence of a CL (kappa = 0.87, delta kappa = +0.05). No improvement was evident for
FNPO (rho = 0.54, delta rho = -0.01). Both radiologists and reproductive endocrinologists
demonstrated improvement in scores (p < 0.001).
Conclusion:  Reliability in evaluating ultrasonographic features of polycystic ovaries can be
significantly improved following participation in a training workshop. If ultrasonographic evidence
of polycystic ovaries is to be used as an objective measure in the diagnosis of PCOS, then
standardized training modules should be implemented to unify the approach to evaluating
polycystic ovarian morphology.
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Background
Diagnostic criteria and management procedures for poly-
cystic ovary syndrome (PCOS) are highly controversial
and hotly debated in the literature [1,2]. The use of ultra-
sonography in the diagnosis of PCOS is one such point of
contention [3]. In 1990, the first attempt by experts to
generate international consensus criteria for PCOS
resulted in exclusion of polycystic ovaries as a potential
marker of the syndrome [4]. While these criteria were her-
alded as a legitimate first step toward characterizing the
clinical spectrum of PCOS, they did override standards
and practices employed in the UK and most of Europe
where the diagnosis had long been based on ultrasonog-
raphy [3]. At the time, evidence of polycystic ovaries was
considered "suggestive" and not diagnostic of PCOS since
there were numerous reports of polycystic ovarian mor-
phology in normal asymptomatic women (up to 30%)
and in conditions other than PCOS such as normal to late
puberty, hyperprolactinemia and congenital adrenal
hyperplasia [5-9].
In the years that followed, it became apparent that poly-
cystic ovaries were in fact, a consistent finding in women
demonstrating biochemical and clinical evidence of
PCOS [10-13]. Moreover, it was discovered that asympto-
matic women with polycystic ovaries demonstrated subtle
endocrine and metabolic abnormalities [3,6,11]. In 2003,
ultrasonographic evidence of polycystic ovaries was incor-
porated as a third diagnostic marker of PCOS at a joint-
meeting of the European Society for Human Reproduc-
tion and Embryology (ESHRE) and American Society for
Reproductive Medicine (ASRM) [1]. Revisions to the con-
sensus criteria were intended to broaden the clinical spec-
trum of PCOS and therefore allowed for a diagnosis based
on identification of two of three criteria: 1) oligo- or
chronic anovulation, 2) clinical and/or biochemical
hyperandrogenism and 3) polycystic ovaries on ultra-
sonography. While there is concern that these criteria are
too expansive [2], they do reflect majority opinion that
polycystic ovaries are a significant component of PCOS.
The current ultrasound guidelines supported by ESHRE/
ASRM define the polycystic ovary as having 12 or more
follicles measuring 2 – 9 mm and/or an increased ovarian
volume of >10 cm3 [1]. Unlike previous definitions, no
assessment of stromal echotexture or follicle distribution
pattern is necessary [5]. The cutoff value for ovarian vol-
ume is based on cumulative reports of mean volumes >10
cm3 for polycystic ovaries [14] while the cutoff value of 12
follicles throughout the entire ovary was shown to have 99%
specificity and 75% sensitivity in distinguishing between
polycystic and normal ovaries [15,16]. At present, the
reproducibility of these values has not been reported nor
has the level of variability associated with the evaluation
of these criteria been established. We are aware of only
one study in which observer variation in the ultrasound
diagnosis of polycystic ovaries has been assessed [17].
Amer et al. showed that when the polycystic ovary was
defined as having ≥ 10 follicles, an ovarian volume ≥ 12
cm3 and a bright echogenic stroma, a diagnosis was agreed
upon among observers only 51% of the time while
observers agreed with themselves only 69% of the time
[17]. Significant variability when making the diagnosis
suggested that the criteria employed were either too sub-
jective or too insensitive to allow for good agreement [14].
Unfortunately, the extent to which any of these features
contributed to the subjectivity of the diagnosis was not
evaluated.
We recently attempted to determine where variability in
the ultrasound diagnosis might lie by determining the
level of inter-observer variability associated with identify-
ing and quantifying individual ultrasonographic features
of polycystic ovaries (e.g., total follicle count, ovarian vol-
ume, etc.) [18]. In our previous study, overall agreement
among radiologists and reproductive endocrinologists
was only moderate to poor. We learned that observers var-
ied significantly in their approach to analyzing each ultra-
sonographic feature and this accounted for discrepancies
in agreement. Differences in technique were mostly
related to differences in training among medical disci-
plines and learning institutions. The primary objective of
the current study was to determine if a training workshop
could reduce inter-observer variation when evaluating
ultrasonographic features of polycystic ovaries. We
hypothesized that agreement among observers could be
vastly improved following the review of relevant Acoustic
Physics principles, ovarian ultrasound image acquisition
and interpretation, and a detailed analysis of ovarian
structures by in vitro water bath scanning.
Methods
Study subjects
Thirty women diagnosed with PCOS by a single primary
care provider were enrolled in the study. PCOS was
defined as having 2 of 3 characteristics: 1) oligo-anovula-
tion (menstrual cycles <21 or >35 days), 2) clinical and/
or biochemical evidence of hyperandrogenism (modified
Ferriman-Gallwey score > 6 [19] and/or a free androgen
index ≥ 5 [20]), 3) polycystic ovaries on ultrasound (≥ 12
follicles measuring 2 – 9 mm in diameter or an ovarian
volume > 10 cm3) [1]. Other etiologies of anovulatory
infertility such as hyperprolactinemia, hypercortisolemia,
thyroid dysfunction and 21-hydroxylase deficiency were
excluded. Subjects had to range in age from 18 to 35 and
could not have used hormonal contraception, fertility
medications or valproate in the three months prior to
enrolment. The ability to visualize at least one ovary by
transvaginal ultrasonography was required for inclusion.Reproductive Biology and Endocrinology 2008, 6:30 http://www.rbej.com/content/6/1/30
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Transvaginal ultrasonography
Study subjects underwent a single transvaginal ultrasound
scan. In all subjects, including those reporting regular
menstrual cycles, the scan occurred at a random time
(during their menstrual cycle). Scans were performed by a
single ultrasonographer using an UltraSonix RP ultra-
sound scanner equipped with a 9-MHz transvaginal probe
(UltraSonix, Version 2.3.5, Vancouver, BC). Ovaries were
scanned from the inner to outer margins in both the trans-
verse and sagittal planes. All scans were recorded digitally.
Digital video clips were subsequently transferred to a cus-
tom-designed database at the Women's Health Imaging
Research Laboratory (WHIRL) at the University of Sas-
katchewan for post-hoc image analysis.
Selection and randomization of ultrasonographic image 
clips
Digital video clips of 30 individual ovaries (one from each
subject) were selected for analysis from the 60 ovaries
scanned. Each ovary was designated an electronic folder
yielding a total of 30 individual "polycystic ovary cases".
Each folder contained 2 digital video clips and a still
image of a single cross-section through the ovary. One
video clip represented a sweep through the ovary in the
transverse plane and the other represented a sweep in the
sagittal plane. Links to these 30 folders were randomly
generated for each of the 6 observers such that no observer
reviewed the cases in the same order. Following the ultra-
sound workshop, links to these folders were reassigned for
each observer ensuring that images were reviewed in a dif-
ferent order than the first.
Evaluation of ultrasonographic records
Two staff radiologists, a senior Radiology resident (fifth
and final year of residency program) and 3 clinician/sci-
entists with training in Reproductive Endocrinology (a
reproductive endocrinologist and 2 research scientists
with training in transvaginal ultrasonography) reviewed
the cases at WHIRL workstations for the following end-
points: 1) follicle number per ovary (FNPO), 2) follicle
number per single cross-section (FNPS), 3) largest follicle
diameter, 4) ovarian volume, 5) follicle distribution pat-
tern and 6) presence of a corpus luteum (CL). For the
FNPO endpoint, observers were asked to count the total
number of follicles ≥ 2 mm in the entire ovary using only
one of the video clips provided (i.e., clearly labeled "for
FNPO"). For the FNPS endpoint, observers were asked to
count the total number of follicles ≥ 2 mm in the single
ovarian cross-section provided. Observers were instructed
to use both video clips to select and measure the follicle
with the largest diameter. Observers were also asked to
judge for each clip (i.e., pattern in the transverse plane and
pattern in the sagittal plane), whether follicles in the ovary
were predominantly distributed in a "peripheral" pattern
or whether follicles were distributed more heterogene-
ously ("even") throughout the stroma. In the event that
neither category could best describe the follicle distribu-
tion pattern, a designation of "other" could be made.
Observers were asked to calculate ovarian volume from
measurements of the largest and widest diameters of the
ovaries in the transverse and sagittal planes using the
equation for a prolate spheroid [π/6 (anterposterior
diameter2 × transverse diameter)] [21]. Lastly, observers
were instructed to use both video clips to determine the
presence or absence of a corpus luteum. Two complemen-
tary software programs (FRAME© and SYNERGYNE 2©,
Saskatoon, SK, Canada) were used to analyze the digital
images. Recordings could be viewed at any speed or direc-
tion including, frame-by-frame analysis. Colour/contrast
adjustments and linear measurements could be made on
any frame of the video clip.
Ultrasound training workshop
Following the first evaluation of the case folders, observ-
ers participated in a 2-hour ultrasound workshop focused
on Acoustic Physics and ovarian ultrasound image acqui-
sition and interpretation. A detailed analysis of ovarian
structures by in vitro water bath scanning and dissection of
bovine ovaries was also performed (i.e. most appropriate
animal model for humans) [22]. Discussion among
observers with regard to their individual approach for
assessing each of the ultrasound parameters resulted in a
list of consensus instructions and tips for re-evaluating
polycystic ovarian morphology (Table 1). Observers were
given 10 days from the date of the ultrasound workshop
to complete their re-evaluation of the case folders. Repre-
sentative images discussed during the workshop are pre-
sented in Figure 1.
Ethical considerations
This study was approved by the University of Saskatch-
ewan Biomedical Research Ethics Review Board. All study
procedures conformed to the Canadian TriCouncil Guide-
lines for Human Research and International Good Clini-
cal Practice Guidelines. Informed consent was obtained
from all volunteers.
Statistical analysis
Descriptive statistics (mean ± SEM and range) of clinical,
hormonal and metabolic features of the study subjects
were generated from clinical and laboratory medical
records obtained at the time of evaluation for PCOS.
Mean measurements (± SEM) for FNPO, FNPS, largest fol-
licle diameter and ovarian volume were calculated and
Tukey's multiple comparison tests were used to determine
if differences among observers before and after the ultra-
sound workshop were significant. Lin's concordance cor-
relation coefficients (·) and kappa statistics for multiple
raters (κ) were used to assess inter-observer agreement for
continuous and discrete measures, respectively [23,24]. PReproductive Biology and Endocrinology 2008, 6:30 http://www.rbej.com/content/6/1/30
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and κ values that approximated 1 denoted perfect agree-
ment while values that approximated 0 denoted agree-
ment no better than that by chance. Guidelines for
evaluating level of agreement were: >0.80 good, 0.60 –
0.80 moderate/fair, <0.60 poor [25]. These empirical
guidelines are more stringent than the highly contested
values originally reported by Landis and Koch [26].
Changes in agreement (Δ· or Δκ) following the ultra-
sound workshop were calculated and Tukey's multiple
comparison tests were used to determine significant




Clinical, hormonal and metabolic features of the study
subjects are summarized in Table 2. Forty-seven percent
(14/30) of volunteers were obese (>30 kg/m2), 10% (3/
30) were overweight (26 – 30 kg/m2) and 43% (13/30)
were lean (<25 kg/m2). Twenty-seven percent (8/30)
reported menstrual cycles every 21 – 35 days, 33% (10/
30) had cycles every 36 – 90 days and 40% (12/30) had
cycles >90 days a part. Eighty-three percent (25/30) of
subjects had hirsutism and 73% (22/30) had an elevated
free androgen index. Ten percent of subjects (3/30) had
no evidence of hirsutism or biochemical hyperandrogen-
emia. Seven percent (2/30) of subjects demonstrated
impaired fasting glycemia while the remaining subjects
had normal fasting glucose levels. Forty percent (12/30)
of subjects were however, categorized as insulin resistant
by an increased homeostatic model assessment of insulin
resistance value.
Overall inter-observer agreement
Scatter plots of pair-wise agreement in FNPO counts,
FNPS counts, largest follicle diameter measurements and
Table 1: Consensus instructions for assessing ultrasonographic features of polycystic ovaries.
Counting ovarian follicles
▪ When counting follicles throughout the entire ovary, scroll through the digital recording using the frame-by-frame feature.
▪ Count a single sweep through the ovary multiple times to generate a consensus count.
▪ When counting follicles in a single plane, adjust contrast to improve visibility/conspicuity of follicles.
▪ Most follicles will appear as round anechoic areas but some follicles, particularly, those atretic, will appear irregularly shaped or compressed.
▪ Consider that discernible walls may not be apparent between adjacent follicles.
▪ Use artifacts of specular reflection to aid in the identification of follicles.
▪ Do not count the cystic cavity of the corpus luteum as a follicle.
Measuring the largest follicle diameter
▪ Convince yourself by scrolling back and forth through the digital recoding that the follicle you have chosen is a single follicle.
▪ Freeze the recording at the frame which represents the largest cross-sectional area of the follicle in question.
▪ Adjust contrast and enlarge the image.
▪ The first linear measurement should be that of the largest longitudinal plane.
▪ Measurements should include the follicle wall as well as any area of acoustic artifact.
▪ The second linear measurement is that which bisects the first line at a right angle.
▪ The mean of these two lines represents the Largest Follicle Diameter.
▪ Make largest follicle measurements for both image clips and report the largest of the two.
▪ Do not count the corpus luteum as the largest follicle.
Calculating ovarian volume and identifying follicle distribution pattern
▪ Convince yourself by moving back and forth through the digital recording that you recognize the limits of the ovary.
▪ Freeze the recording at the frame which represents of the largest cross-sectional area.
▪ Adjust contrast and enlarge the image.
▪ Decide on the follicle distribution pattern in this cross-section (i.e. peripheral or even).
▪ If this image contains a follicle ≥ 10 mm or a large cystic CL, designate the follicle pattern as other.
▪ The first linear measurement should be that of the largest longitudinal plane.
▪ Draw your line keeping in mind that small round anechoic areas may lie outside the ovarian capsule (i.e. small vessels that should not be confused 
as follicles) and that an area of acoustic artifact may be present.
▪ The second linear measurement should represent the widest plane of the ovary and should cross the longitudinal measurement at a right angle.
▪ Repeats these measurements for the second clip and use the averages of the longitudinal and antero-posterior measurements to calculate volume.
Identifying corpora lutea (CL)
▪ CL may appear as a large cystic structure or a smaller hyperechoic structure with a small to negligible fluid-filled cavity.
▪ Walls of the CL are generally thick, hyperechoic and crenulated.
▪ The cystic cavity of CL generally has heterogeneous areas of echogenicity.
▪ Ensure that you can identify the CL in both sagittal and transverse planes before deciding on its presence.Reproductive Biology and Endocrinology 2008, 6:30 http://www.rbej.com/content/6/1/30
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Ultrasonographic image attributes encountered during the inter-observer evaluation of polycystic ovaries are presented Figure 1
Ultrasonographic image attributes encountered during the inter-observer evaluation of polycystic ovaries are 
presented. Panels A, B and C represent sequential images through a polycystic ovary where an apparently 'even' distribution 
of follicles is evident at the end of the ovary while a peripheral distribution of follicles is evident at the central portion of the 
ovary (Panel C). Designation of follicle pattern was to be made at the largest cross-sectional image of the ovary. Panels D, E 
and F depict sequential images through a polycystic ovary containing a large dominant follicle (DF). An area of acoustic artifact 
(arrows) is present along the top portion of the dominant follicle closest to the transducer (Panels E and F). Both the follicle 
wall and area of acoustic artifact were to be included in the measurements of the largest follicle diameter (Panel F). Panels G, H 
and I demonstrate sequential images through a polycystic ovary containing a large cystic corpus luteum (CL). The cystic CL has 
a hyperechoic crenulated border and a flocculent fluid filled cavity. A polycystic ovary containing a CL with thick hyperechoic 
walls and a small fluid-filled cavity is presented in Panel J for comparison with Panel I. A polycystic ovary containing a concen-
trated collection of follicles along the lower margin of the ovary is presented in Panel K. The number of follicles counted would 
depend on the number of lobulations perceived among the "string of pearls". Areas of specular reflection (arrows) could be 
used to aid in the identification of some individual follicles. A transverse cross-section through an irregular shaped polycystic 
ovary is shown in Panel L. Estimations of the longest and widest orthogonal diameters of the ovary were to be made for esti-
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ovarian volume calculations by the six observers are pre-
sented in Figure 2. Perfect agreement corresponds to a
slope of 1 (diagonal line). Before the ultrasound work-
shop, inter-observer agreement was best for ovarian vol-
ume and largest follicle diameter and poorest for FNPO
and FNPS. Following the ultrasound workshop, visible
improvement as judged by an increase in the number of
points aggregating along the diagonal line was apparent
in the assessment of FNPS (compare 2C and 2D), largest
follicle diameter (compare 2E and 2F) and ovarian vol-
ume (compare 2G and 2H). No improvement in the eval-
uation of FNPO was evident (compare 2A and 2B).
Before the workshop, FNPO and FNPS counts were 35.6 ±
0.9 and 11.8 ± 0.3 follicles, respectively. Measurements of
the largest follicle diameter were 7.8 ± 0.3 mm and ovar-
ian volume measurements were 9.7 ± 0.3 cm3. Following
the workshop, FNPO counts (42.9 ± 1.0 follicles, p <
0.0001), FNPS counts (14.3 ± 0.4 follicles, p < 0.0001)
and ovarian volume measurements (13.1 ± 0.3 cm3, p <
0.0001) were higher than those reported before the work-
shop. By contrast, measurements of largest follicle diame-
ter were similar to those made before the workshop (8.1 ±
0.4 mm, p = 0.09). Both before and after the ultrasound
workshop, all cases fulfilled the criteria for the diagnosis
of a polycystic ovary based on ESHRE/ASRM guidelines of
≥ 12 follicles per ovary. At no time did observers make
counts lower than 12 follicles per ovary (even in the pres-
ence of a dominant follicle or CL). Measurements made
by radiologists (RAD) and reproductive endocrinologists
(REI) are presented in Table 3. Before the workshop, RAD
and REI made similar measurements for FNPO and ovar-
ian volume but not for FNPS (p = 0.0001) or largest folli-
cle diameter (p = 0.002). Differences in FNPS and largest
follicle measurements were resolved following the work-
shop although, RAD tended to make larger ovarian vol-
ume measurement post-workshop (p = 0.001).
The overall level of pair-wise agreement among the six
observers before and after the ultrasound workshop is
summarized in Table 4. Before the workshop, agreement
between pairs of observers ranged from 0.25 to 0.78 for
the assessment of FNPO, 0.33 to 0.91 for FNPS, 0.37 to
0.96 for largest follicle diameter, 0.45 to 0.87 for ovarian
volume, 0.69 to 0.93 for presence of a CL and 0.26 to 0.90
for follicle distribution pattern (Note: data were com-
bined for pattern in the sagittal and transverse planes
since no differences were detected). Overall inter-observer
agreement for continuous and discrete measures was fair
(· = 0.63 and κ = 0.71, respectively). Following the work-
shop, agreement between pairs of observers increased for
all parameters except FNPO. Post-workshop agreement
ranged from 0.49 to 0.81 for FNPS (p = 0.01), 0.52 to 0.98
for largest follicle diameter (p = 0.13), 0.77 to 0.90 for
ovarian volume (p = 0.0004), 0.76 to 0.97 for presence of
a CL (p = 0.08) and 0.69 to 0.97 for follicle distribution
(p = 0.0001). Overall inter-observer agreement for contin-
uous and discrete measures was significantly improved (·
= 0.71; p = 0.0003 and κ = 0.84; p = 0.001).
Agreement among RAD and REI assessing ultrasono-
graphic features of polycystic ovaries before and after the
ultrasound workshop are presented in Table 5. Before the
workshop, RAD demonstrated better agreement in the
Table 2: Clinical, hormonal and metabolic features of PCOS study subjects.
Mean ± SEM Range Normal Values
Age (yr) 28.5 ± 0.7 19 – 35 -
BMI (kg/m2) 30.1 ± 1.4 19.4 – 45.0 20 – 25
Waist Circumference (cm) 95.3 ± 3.1 70.0 – 140.0 < 88
Menstrual Cycle Length (d) 106 ± 17 25 – 365 21 – 35
mFG Score 9.6 ± 1.1 0 – 24 < 6
Testosterone (nmol/L) 2.3 ± 0.2 0.75 – 5.0 < 2.5
SHBG (nmoll/L) 46.7 ± 4.2 13.0 – 97.2 18 – 114
Free Androgen Index 6.1 ± 0.7 1 – 19 < 5
DHEA-S (μmol/L) 5.1 ± 0.3 2.2 – 8.8 0.9 – 12.0
17OH-Progesterone (nmol/L) 3.8 ± 0.4 1.2 – 11.2 0.3 – 12.1
LH:FSH Ratio 2.3 ± 0.3 0.6 – 7.7 < 2
Cortisol (nmol/L) 303 ± 23 130 – 640 130 – 640
Prolactin (μg/L) 13.1 ± 0.9 4.4 – 20.0 3.0 – 20.0
TSH (mIU/L) 1.9 ± 0.2 0.5 – 4.8 0.3 – 5.5
Fasting Glucose (mmol/L) 4.9 ± 0.1 4.2 – 6.7 < 6.1
Fasting Insulin (pmol/L) 78.1 ± 9.4 21.0 – 185.0 < 100
HOMA-IR 3.0 ± 0.4 0.7 – 8.1 < 3
Normative values for the local health region are provided. Body mass index (BMI), modified Ferriman-Gallwey (mGF), sex hormone binding globulin 
(SHBG), dehydroepiandrosterone sulfate (DHEA-S), follicle stimulating hormone (FSH), luteinizing hormone (LH), thyroid stimulating hormone 
(TSH), homeostatic model assessment of insulin resistance (HOMA-IR).Reproductive Biology and Endocrinology 2008, 6:30 http://www.rbej.com/content/6/1/30
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Scatter plots of follicle number per ovary counts (FNPO; A and B), follicle number per single cross-section counts (FNPS; C  and D), largest follicle diameter measurements (E and F) and ovarian volume calculations (G and H) by all possible pair-wise  combinations of the six observers before and after the ultrasound workshop are presented Figure 2
Scatter plots of follicle number per ovary counts (FNPO; A and B), follicle number per single cross-section 
counts (FNPS; C and D), largest follicle diameter measurements (E and F) and ovarian volume calculations (G 
and H) by all possible pair-wise combinations of the six observers before and after the ultrasound workshop 
are presented. Perfect agreement between two observers corresponds to a slope of 1 (diagonal line). Before the workshop, 
agreement was best for ovarian volume and largest follicle diameter and poorest for FNPO and FNPS. Following the workshop, 
visible improvement was apparent for FNPS, largest follicle diameter and ovarian volume. No improvement in FNPO was evi-
dent.Reproductive Biology and Endocrinology 2008, 6:30 http://www.rbej.com/content/6/1/30
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evaluation of FNPS (p = 0.01) and distribution pattern (p
= 0.01) while REI demonstrated better agreement in meas-
urements of largest follicle diameter (p = 0.01). Following
the workshop, differences when evaluating FNPS, largest
follicle and distribution pattern were resolved. Overall
agreement following the ultrasound workshop was simi-
lar among REI and RAD for continuous measures (· =
0.71 vs. 0.71, p = 0.98). However, REI demonstrated bet-
ter agreement for discrete measures (κ = 0.88 vs. 0.79,
respectively; p = 0.01).
Discussion
Our objective was to determine the effect of an ultrasound
training workshop on the inter-observer variability associ-
ated with evaluating ultrasonographic features of poly-
cystic ovaries. Our approach involved the assessment of
transvaginal ultrasound recordings of 30 polycystic ova-
ries for six features, by six observers with training in either
Radiology or Reproductive Endocrinology, both before
and after an ultrasound workshop. The use of ultrasono-
graphic recordings for the determination of inter-observer
variability is a commonly used and highly feasible
approach [17]. It involved volunteers undergoing only
one endovaginal scan and avoided the presence of numer-
ous observers in the ultrasound suite which may be con-
sidered intrusive or embarrassing for the study participant
[17]. Furthermore, it mimicked practices in Radiology
where digital images/recordings captured by trained
sonographers are presented to radiologists for post-hoc
evaluation. Had it been practical to have six observers per-
form their own scans, we suspect that differences in train-
ing, technique and experience at the time of image
acquisition would have further compounded the level of
variability reported among observers.
Observers were given minimal instructions prior to their
initial analysis of the images in hopes that each observer
would best use his or her own skill-set in the assessments.
Agreement was initially poor for FNPO, FNPS and follicle
distribution pattern, moderate for largest follicle diameter
and ovarian volume, and good for identification of a CL.
These findings were consistent with our previous study in
which four observers analyzed transvaginal ultrasound
recordings of polycystic ovaries for similar morphologic
endpoints [18]. The results of our current study showed
that inter-observer agreement could be significantly
improved when observers participated in a workshop
focused on evaluating ovarian morphology. Discussion
among radiologists and reproductive endocrinologists
which culminated in the formation of consensus guide-
lines for assessing ultrasonographic features was the pri-
mary factor responsible for improved agreement
following the ultrasound workshop.
The current ESHRE/ASRM recommendations for the ultra-
sonographic evaluation of polycystic ovaries state that
ultrasound scans (preferably, transvaginal) be performed
during the early follicular phase (i.e., days 3 – 5) or three
to five days following a hormonally-induced bleed in
women with chronic anovulation [1]. This recommended
time of ultrasonography corresponds to a time during the
natural menstrual cycle in which follicle population is
dramatically increasing, yet maximum follicle diameters
are generally <10 mm [27]. Despite these recommenda-
Table 3: Ultrasonographic measurements made by radiologists and reproductive endocrinologists before and after an ultrasound 
workshop.
FNPO FNPS Largest Follicle (mm) Ovarian Volume (cm3)
Before After Before After Before After Before After
RAD 34.5 ± 1.4a 42.8 ± 1.6b 11.0 ± 0.4c 14.4 ± 0.5d 7.1 ± 0.4f 8.1 ± 0.5g 9.7 ± 0.4h 13.5 ± 0.4i
REI 36.6 ± 1.1a 43.1 ± 1.3b 12.6 ± 0.5e 14.1 ± 0.5d 8.3 ± 0.5g 8.1 ± 0.5g 9.6 ± 0.4h 12.7 ± 0.4j
Different letters represent significant differences between groups (p > 0.05) both before and after the ultrasound workshop.
Table 4: Level of pair-wise agreement for six observers assessing ultrasonographic features of polycystic ovaries before and after an 
ultrasound workshop.
Overall Concordance Correlation Coefficient (ρ) Overall Kappa Statistic (κ)









BEFORE 0.55 0.59 0.67 0.72 0.63 0.82 0.59 0.71
AFTER 0.54 0.70 0.77 0.84 0.71 0.87 0.80 0.84
Δρ/Δκ -0.01 +0.11 +0.10 +0.12 +0.08 +0.05 +0.21 +0.13
P-value 0.73 0.01 0.13 0.0004 0.0003 0.08 0.0001 0.001Reproductive Biology and Endocrinology 2008, 6:30 http://www.rbej.com/content/6/1/30
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tions, many women still present for ultrasonographic
evaluation at random times during their menstrual cycle.
We felt it instructive to mimic real-life situations by hav-
ing participants present for their ultrasounds at random
such that observers would encounter multiple follicle
sizes and/or ovulation glands when assessing polycystic
ovarian morphology. While we recognize that not all the
ultrasonographic endpoints assessed are used to diagnose
polycystic ovaries, each of these features is routinely eval-
uated at the time of ovarian ultrasonography since each
gives important information regarding ovarian function/
dysfunction.
Poor agreement in the evaluation of FNPO demonstrated
by this current study was in contrast to past reports of very
good inter-observer agreement in total antral follicle
counts (2 – 10 mm) using real-time or stored 2D and 3D
transvaginal ultrasonographic imaging [28,29]. In previ-
ous studies, good agreement among observers was associ-
ated with antral follicle counts in the order of
approximately 10 follicles per ovary [28,29]. However, it
should be noted that both groups also reported a distinct
decrease in inter-observer agreement when follicle counts
were greater than 15 [28,29]. In the present study, follicle
counts in women diagnosed with PCOS by the ESHRE/
ASRM criteria generally ranged from 35 – 40. That we were
counting more than three times as many follicles per
ovary may have accounted for differences in agreement
between studies. That there were fewer follicles to count in
a single cross-section (i.e., ~12 follicles), may have also
accounted for the better agreement levels reported for
FNPS compared to FNPO.
Difficulty in counting follicles lay in the high degree of
crowding that occurred among adjacent follicles. In hav-
ing performed an ultrasono-histopathological assessment
of bovine ovaries, it was apparent that follicles could
appear as either round or irregular in shape due to atresia
or compression by adjacent structures. It was also evident
that follicle clustering caused adjacent follicular walls to
be imperceptible on ultrasonography. Discriminating
among adjacent follicles would therefore, depend on the
observer's perception of the number of lobulations
present among a collection of cysts rather than the identi-
fication of septa between follicles. With these points in
mind, significant improvement in the assessment of FNPS
was evident following the ultrasound workshop.
Improvement resulted even though mean FNPS counts
were significantly higher than those reported before the
ultrasound workshop. The higher follicle counts likely
reflected an improved awareness of what actually consti-
tuted an ovarian follicle on ultrasonography.
An increase in mean follicle counts was also reported for
the assessment of FNPO following the ultrasound work-
shop. However, unlike the FNPS endpoint, inter-observer
agreement was not improved for FNPO. Failure to
improve agreement in FNPO may be interpreted to mean
that the level of subjectivity associated with counting fol-
licles throughout the entire ovary is insurmountable. The
current ultrasound recommendations argue that the abil-
ity to reliably count 12 follicles is sufficient to ensure an
accurate diagnosis. Our study supports the notion that
multiple observers can agree on counting at least 12 folli-
cles per ovary. However, there is merging evidence that
total follicle population relates to degree of symptomol-
ogy and therefore, health risks for women with PCOS
[30]. Ascertaining the clinical relevance of discrete aspects
of ovarian morphology may therefore help identify per-
sons at risk for PCOS and/or progression of the syndrome.
Differences in ovarian volume measurements before the
ultrasound workshop were related to differences in meas-
urement technique among observers. Some observers
would measure the widest and longest orthogonal planes
of the ovary while others would measure the longest plane
first and then draw their width measurement such that it
bisected the longitudinal plane at a right angle (i.e., this
may or may not have represented the widest plane of the
ovary). After agreeing to uniformly measure only the long-
est and widest orthogonal planes, ovarian volume meas-
urements were significantly greater following the
workshop and inter-observer agreement for ovarian vol-
ume proved excellent. This was consistent with several
studies reporting good inter-observer agreement in the
ultrasound assessment of ovarian volume [31-34]. The
Table 5: Agreement among radiologists and reproductive endocrinologists assessing ultrasonographic features of polycystic ovaries 
before and after an ultrasound workshop.








Before After Before After Before After Before After Before After Before After
RAD 0.55a 0.56a 0.71b 0.70b 0.55d 0.69d, e 0.66f 0.88f 0.84g 0.82g 0.68h 0.76h, i
REI 0.49a 0.50a 0.51c 0.65b 0.86e 0.85e 0.71f 0.83f 0.82g 0.93g 0.48j 0.83i
Different letters represent significant differences between groups (p > 0.05) both before and after the ultrasound workshop.Reproductive Biology and Endocrinology 2008, 6:30 http://www.rbej.com/content/6/1/30
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subjectivity associated with counting follicles may be
interpreted to suggest that calculation of ovarian volume
should represent the primary method of diagnosing poly-
cystic ovaries. Unfortunately, there are limitations to
determining ovarian volume that must be acknowledged.
For example, accurate measurements of ovarian volume
can only be made during the early follicular phase when
there is generally no dominant follicle (>10 mm) or cystic
CL to overestimate the size of the ovary. Cutoff levels for
increased ovarian volume in polycystic ovaries are debat-
able since there is significant overlap with the normal
population [35]. Also, it is important to note that not all
polycystic ovaries will be enlarged despite demonstrating
a grossly elevated follicle count [14]. More importantly,
there is no universally accepted method of calculating
ovarian volume [14]. In this study, we employed the
equation for a prolate spheroid to calculate ovarian vol-
ume rather than the equation for a prolate ellipsoid which
is recommended by the ESHRE/ASRM consensus. The
equation for a prolate spheroid was found to correlate bet-
ter with volume measurements of polycystic ovaries made
by 3D-ultrasonography than the formula for a prolate
ellipsoid [21].
The most improvement in agreement was seen for the
evaluation of follicle distribution pattern. Before the
workshop, many observers expressed clear frustration and
reluctance to assign a distribution pattern since digital
sweeps through the ovary would often show both even
and peripheral follicle distribution patterns depending on
what portion of the ovary was represented. After discus-
sion, it was concluded that the designation follicle pattern
should occur at the single largest cross-sectional view of
the ovary in keeping with previous definitions of poly-
cystic ovarian morphology [5]. That is, observers would
now scroll to the digital frame that represented the largest
cross-sectional area of the ovary and decide on both folli-
cle pattern and measurements of the widest and longest
diameters of the ovary (i.e., for measurement of ovarian
volume) using that individual frame. It was decided that
in instances where a preovulatory follicle or a cystic CL
was present in the largest plane a designation of 'other' be
made. Inter-observer agreement for evaluation of follicle
distribution pattern became exceptional following this
consensus approach.
The presence of an ovulation gland is a highly important
finding to report in women with PCOS given its implica-
tions for fertility and risk of endometrial hyperplasia.
While CL are typically identifiable during the luteal phase,
it is important to recognize that CL, albeit non-functional,
may be visualized ultrasonographically during the early
follicular phase coinciding with the recommended time
for evaluation of PCOS [36]. Following the ultrasound
workshop, agreement in the identification of a CL was
good among virtually all pairs of observers. Disagreement
among observers was typically noted only when a CL
appeared as a cystic structure versus when it appeared as a
hyperechoic structure with a small to negligible fluid-
filled cavity [36]. In these instances, there was a tendency
to mistake a cystic CL for a dominant preovulatory folli-
cle. Mistaking a CL for a large follicle also accounted for
outlier measurements of the largest follicle diameter.
Clues recognized by the observers as being helpful in dis-
tinguishing between CL and preovulatory follicles
included the presence of a floccuent cystic cavity and/or
crenulated hyperechoic postovulatory follicular walls
which are apparent only in CL. Had observers performed
their own ultrasound scans, the use of Doppler in real-
time could have facilitated the identification of CL and
likely improved agreement among observers for this end-
point [36].
In summary, variability in the ultrasound diagnosis of
polycystic ovaries likely reflects poor to moderate inter-
observer agreement when identifying and quantifying
individual characteristics of polycystic ovaries. Agreement
in assessing ultrasonographic features of polycystic ova-
ries can be significantly improved when evaluators gener-
ate consensus guidelines for assessing ultrasonographic
endpoints. Our study supports the notion that standard-
ized training modules for characterizing polycystic ovar-
ian morphology are needed if ultrasonographic evidence
of polycystic ovaries is to be used as an objective measure
in the diagnosis of PCOS. Also, that collaboration and
communication among imaging specialists in different
medical disciplines is necessary for generating a truly con-
sensual approach. Developing reliable and unified meth-
ods for the acquisition and interpretation of
ultrasonographic images of polycystic ovaries is critical for
ensuring the timely identification and intervention of
PCOS.
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